Stefan R Bornstein Selected Research

Neoplasm Metastasis (Metastasis)

10/2018	Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
7/2012	Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
2/2007	Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
8/2006	Gene expression profiling of benign and malignant pheochromocytoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan R Bornstein Research Topics

Disease

39	Insulin Resistance 01/2024 - 05/2002
36	Type 2 Diabetes Mellitus (MODY) 01/2024 - 07/2007
34	Pheochromocytoma 01/2024 - 03/2002
31	Neoplasms (Cancer) 01/2024 - 03/2002
29	Obesity 04/2024 - 11/2004
23	Inflammation (Inflammations) 01/2024 - 06/2002
14	COVID-19 01/2024 - 01/2020
14	Paraganglioma (Paragangliomas) 12/2023 - 03/2002
12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 12/2010
11	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2023 - 02/2002
9	Hypertension (High Blood Pressure) 12/2023 - 11/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 09/2006
9	Sepsis (Septicemia) 01/2019 - 05/2003
8	Hyperglycemia 01/2024 - 05/2010
8	Adrenocortical Carcinoma 08/2023 - 03/2005
8	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2017
8	Diabetes Mellitus 10/2020 - 08/2011
7	Fibrosis (Cirrhosis) 01/2024 - 04/2012
7	Adenoma (Adenomas) 08/2023 - 06/2002
7	Necrosis 01/2023 - 01/2018
7	Infections 08/2022 - 09/2004
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 05/2002
7	Glucose Intolerance 01/2021 - 01/2009
6	Hypoglycemia (Reactive Hypoglycemia) 11/2023 - 12/2010
6	Weight Loss (Weight Reduction) 11/2022 - 05/2017
6	Body Weight (Weight, Body) 10/2021 - 11/2015
6	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2018 - 02/2002
5	Heart Failure 11/2022 - 05/2006
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 11/2010
5	Cushing Syndrome 07/2017 - 06/2002
5	Multiple Endocrine Neoplasia Type 2a (MEN 2) 03/2011 - 08/2006
4	Fatty Liver 01/2024 - 10/2014
4	Disease Progression 11/2023 - 11/2014
4	Metabolic Diseases (Metabolic Disease) 08/2023 - 01/2020
4	Dyslipidemias (Dyslipidemia) 01/2023 - 04/2012
4	Overweight 01/2023 - 11/2004
4	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 11/2013
4	Hyperaldosteronism (Conn Syndrome) 01/2022 - 12/2013
4	Ischemia 01/2022 - 01/2005
4	Parkinson Disease (Parkinson's Disease) 01/2020 - 11/2003
4	Neoplasm Metastasis (Metastasis) 10/2018 - 08/2006
4	Hyperplasia 03/2016 - 02/2002
3	Prediabetic State (Prediabetes) 11/2023 - 10/2016
3	Addison Disease (Addison's Disease) 09/2023 - 01/2005
3	Neuroblastoma 08/2023 - 01/2010
3	Alcoholic Fatty Liver 01/2023 - 01/2021
3	Critical Illness (Critically Ill) 08/2022 - 07/2008
3	Hypersensitivity (Allergy) 01/2022 - 03/2008

Drug/Important Bio-Agent (IBA)

37	Insulin (Novolin)FDA Link 01/2024 - 05/2002
30	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 04/2003
19	LipidsIBA 11/2023 - 05/2002
19	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2023 - 02/2002
18	AldosteroneIBA 03/2024 - 05/2002
18	CatecholaminesIBA 01/2022 - 09/2004
15	Hormones (Hormone)IBA 11/2023 - 05/2003
15	GlucocorticoidsIBA 01/2023 - 05/2002
14	Proteins (Proteins, Gene)FDA Link 12/2022 - 06/2002
12	Biomarkers (Surrogate Marker)IBA 07/2023 - 02/2002
11	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2015 - 02/2002
10	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2013 - 11/2004
9	Lipoproteins (Lipoprotein)IBA 12/2019 - 07/2012
8	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 08/2006
8	NormetanephrineIBA 01/2023 - 03/2011
8	Triglycerides (Triacylglycerol)IBA 10/2021 - 01/2009
8	oxidized low density lipoproteinIBA 01/2020 - 10/2007
7	MetanephrineIBA 01/2023 - 02/2011
7	SteroidsIBA 08/2022 - 11/2004
6	EnzymesIBA 01/2024 - 09/2004
6	3-methoxytyramine (methoxytyramine)IBA 01/2023 - 03/2011
6	IronIBA 01/2022 - 03/2011
5	AutoantibodiesIBA 01/2024 - 11/2017
5	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2023 - 08/2006
5	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
5	Messenger RNA (mRNA)IBA 01/2021 - 06/2002
5	Blood Glucose (Blood Sugar)IBA 10/2020 - 04/2003
5	Dopamine (Intropin)FDA LinkGeneric 10/2018 - 11/2003
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2018 - 08/2006
5	CorticosteroneIBA 07/2017 - 04/2006
4	CytokinesIBA 12/2022 - 06/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 02/2015
4	AntibodiesIBA 01/2022 - 01/2016
4	citrate-binding transport proteinIBA 01/2020 - 12/2015
4	AdiponectinIBA 01/2020 - 01/2011
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 01/2009
4	CholesterolIBA 05/2019 - 07/2009
4	Dehydroepiandrosterone (DHEA)IBA 07/2017 - 05/2003
4	AndrogensIBA 01/2008 - 05/2002
3	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 03/2024 - 04/2012
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2024 - 02/2010
3	Glucagon (Glukagon)FDA Link 05/2023 - 11/2008
3	ProinsulinIBA 01/2023 - 05/2010
3	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2023 - 07/2010
3	Hypoglycemic Agents (Hypoglycemics)IBA 11/2022 - 10/2015

Therapy/Procedure

27	Therapeutics 03/2024 - 04/2003
14	Blood Component Removal (Apheresis) 07/2023 - 12/2009
12	Bariatric Surgery 01/2023 - 11/2017
7	Transplantation 11/2023 - 01/2010
5	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2021 - 01/2018
4	Glycemic Control 08/2019 - 12/2010
3	Adrenalectomy 01/2022 - 08/2011